Snap-8 (Acetyl Octapeptide-3)
A topical cosmetic peptide (acetyl octapeptide-3) targeting expression lines; lawful in cosmetics, with small appearance-level studies behind it.
What it is
Snap-8 (acetyl octapeptide-3) is a topical cosmetic peptide marketed as a 'Botox-like' softener of expression lines — an extended version of the famous Argireline hexapeptide, often formulated with hyaluronic acid.
It lives in the lawful cosmetic world: real ingredient, modest evidence, appearance-level claims. In-vitro work and small cosmetic studies support some reduction in the look of expression wrinkles; nothing about it approaches actual neuromodulator injections in effect or evidence.
What researchers have actually studied it for
The appearance of expression wrinkles in small topical cosmetic studies; a lawful cosmetic ingredient with cosmetic-tier evidence.
How it works
It mimics a fragment of SNAP-25, a protein in the machinery nerve endings use to release acetylcholine — the same complex botulinum toxin destroys. The peptide's claimed effect is mild interference with that signaling at the skin level when applied topically; how much survives the skin barrier is the operative question.
Where it came from
Developed by Lipotec (the Barcelona group behind Argireline) as the octapeptide successor in the 2000s 'topical Botox alternative' wave, Snap-8 became a staple of serum formulations — usually paired with hyaluronic acid for the immediate plumping effect that flatters any before-and-after.
What the research record actually contains
- In-vitro SNARE-complex interference studies.
- Small manufacturer-associated cosmetic studies reporting reduced wrinkle depth measurements.
- No drug-tier trials — and no basis for comparing it to injectable neuromodulators.
What's known about risks
Well tolerated as a cosmetic ingredient; the hyaluronic-acid pairing is likewise benign. Injectable use of cosmetic peptides — which some gray-market sellers push — abandons both the evidence and the lawful channel.
Where it stands legally
Lawful as a topical cosmetic ingredient; makes no approved drug claims, and any injectable form sits outside regulation entirely.
Worth asking a licensed provider
- 1.For expression lines, how do topical peptides realistically compare with retinoids or neuromodulator injections?
- 2.What's a realistic effect size and timeline from cosmetic-tier evidence?
- 3.Is my formulation question really a dermatologist conversation?